Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Histogen (HSTO) stocks in Canada

Learn how to easily invest in Histogen stocks.

Histogen is a biotechnology business based in the US. Histogen stocks (HSTO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.93 – a decrease of 17.04% over the previous week. Histogen employs 19 staff and has a trailing 12-month revenue of around $1.5 million.

How to buy shares in Histogen

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HSTO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Histogen stock price (NASDAQ:HSTO)

Use our graph to track the performance of HSTO stocks over time.

Histogen shares at a glance

Information last updated 2022-01-24.
Latest market close$0.22
52-week range$0.22 - $1.98
50-day moving average $0.41
200-day moving average $0.77
Wall St. target price$2.70
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.49

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Histogen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Histogen price performance over time

Historical closes compared with the close of $0.224 from 2022-01-26

1 week (2022-01-21) -13.08%
1 month (2021-12-27) -34.92%
3 months (2021-10-28) -68.21%
6 months (2021-07-28) -73.01%
1 year (2021-01-28) -80.85%
2 years (2020-01-28) -45.15%
3 years (2019-01-28) 1.75
5 years (2017-01-27) 4.24

Histogen financials

Revenue TTM $1.5 million
Gross profit TTM $-5,022,000
Return on assets TTM -47.67%
Return on equity TTM -113.61%
Profit margin 0%
Book value $0.51
Market capitalisation $12 million

TTM: trailing 12 months

Histogen share dividends

We're not expecting Histogen to pay a dividend over the next 12 months.

Have Histogen's shares ever split?

Histogen's shares were split on a 1:10 basis on 27 May 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Histogen shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Histogen shares which in turn could have impacted Histogen's share price.

Histogen overview

Histogen Inc. , a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company's pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. .

Stocks similar to Histogen

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

COVID testing stocks

COVID testing stocks

We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.

Read more…


Review the benefits and risks of investing in these tech-focused ETFs.

Read more…

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site